JP Stock MarketDetailed Quotes

4502 Takeda Pharmaceutical

Watchlist
  • 4230.0
  • -55.0-1.28%
20min DelayMarket Closed Jul 19 15:00 JST
6.73TMarket Cap46.40P/E (Static)

Takeda Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Takeda Pharmaceutical Earnings Date

Currency: JPY

Period

Q1 FY2025 Estimates

Jul 31, 2024

Revenue(YoY)

1.08T

+2.14%
EPS(YoY)

40.40

-29.75%
Analyst Rating

Buy

Jul 17, 2024

Takeda Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Oct 31, 20242025/Q2-- / 1.088T--
Jul 31, 20242025/Q1-- / 1.081T--
May 9, 20242024/Q41.051T / 899.902B--
Feb 1, 20242024/Q31.111T / 1.001T--
Oct 26, 20232024/Q21.043T / 990.336B--
DatePeriodRevenue/EstimateEarnings Call
Oct 31, 20242025/Q2-- / 1.088T--
Jul 31, 20242025/Q1-- / 1.081T--
May 9, 20242024/Q41.051T / 899.902B--
Feb 1, 20242024/Q31.111T / 1.001T--
Oct 26, 20232024/Q21.043T / 990.336B--

Unlock Free Earnings Estimates

Takeda Pharmaceutical Earnings Reports

  • Takeda Pharmaceutical: Extraordinary Report

    Jul 1 22:53 ET

  • Takeda Pharmaceutical: Confirmatory letter.

    Jun 26 03:02 ET

  • Takeda Pharmaceutical: Financial Report - 147th Term (2023/04/01 - 2024/03/31)

    Jun 26 03:01 ET

  • Takeda Pharmaceutical: (Correction) Partial revisions to financial results summary [IFRS] (consolidated) for the fiscal year ending March 31, 2024

    May 21 02:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 17, 2024

    Buy

    • Strong Buy

      38.89%

    • Buy

      11.11%

    • Hold

      50.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    %Chg